small molecule phosphofructokinase-2 inhibitors (Quantum Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesmall molecule phosphofructokinase-2 inhibitors (Quantum Pharmaceuticals)
Drug Alias Nameglycolysis inhibitors (Quantum Pharmaceuticals)aminofurazan-triazoles (Quantum Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 inhibitors
Targets6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3
Therapy Area/IndicationsNerve DegenerationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesQuantum Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQuantum Pharmaceuticals LLC
Active IndicationsN/A
Inactive IndicationsNerve DegenerationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A